Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 168 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

 		Hidradenitis Suppurativa Russia NCT06517732

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

 		Spinal Muscular Atrophies Brazil NCT06019637

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

 		Follicular Lymphoma (FL) Phase3 Australia
Austria
Canada
Czechia
Hungary
Poland
Romania
Singapore
Slovakia
South Korea
Spain
Taiwan
United States
View all
 NCT05888493

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

 		Prostatic Neoplasms, Castration-Resistant Phase1 Australia
South Africa 		NCT04597411

Study of Out of Specification for Tisagenlecleucel

 		B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Phase3 Japan NCT04094311

Kesimpta Pregnancy and Infant Safety Study Using Real World Data

 		Multiple Sclerosis Switzerland NCT06156683

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

 		Multiple Sclerosis United States NCT04933552

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

 		C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis Phase3 Argentina
Brazil
China
France
Germany
Greece
Israel
Italy
Japan
Netherlands
Spain
Switzerland
Turkey (Türkiye)
United Kingdom
United States
View all
 NCT03955445

Regulatory Post-Marketing Surveillance Study for Brolucizumab

 		Neovascular Age-related Macular Degeneration South Korea NCT04985487

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

 		Graft-versus-Host Disease South Korea NCT05621733